Kremezin Study Against Renal Disease Progression in Korea

NCT00860431 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

578

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: AST-120

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]